Formamide-Free Hybridization Buffer for RNA Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in situ hybridization (ISH) methods for detecting small non-coding RNAs, particularly microRNAs, in formalin-fixed, paraffin-embedded (FFPE) tissue samples face challenges due to RNA degradation from formalin fixation and the use of teratogenic formamide in hybridization buffers, leading to sensitivity issues and high background levels.
Innovation Solution
A formamide-free hybridization buffer containing chaotropic agents like urea or guanidine hydrochloride is used, which enhances detection sensitivity and specificity for small non-coding RNAs, allowing for semi-quantitative analysis and diagnostic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If formamide is used in hybridization buffer, then hybridization efficiency is improved, but teratogenic effects and safety issues worsen
Solution Approach 1:
The patent replaces formamide with alternative chemicals (chaotropic agents like guanidine thiocyanate, urea, or lithium chloride) in the hybridization buffer, changing the chemical composition parameters while maintaining hybridization functionality. This substitution eliminates the teratogenic effects of formamide while preserving detection sensitivity through optimized salt concentrations and compositions.
2Stability of the object's composition
If formalin fixation time is extended, then tissue fixation quality is improved, but RNA degradation increases
Solution Approach 1:
The patent applies preliminary RNase inhibition by incorporating RNase inhibitors and optimizing fixation protocols to minimize RNA degradation before hybridization. By addressing RNA protection in advance during the fixation process, the method preserves RNA integrity even with extended fixation times required for quality tissue preparation.
3Measurement precision
If sensitivity for small non-coding RNA detection is improved, then diagnostic accuracy is improved, but background levels increase
Solution Approach 1:
The patent employs LNA (Locked Nucleic Acid) probes with localized modifications that enhance binding affinity and specificity at the probe-target interface. The LNA chemistry provides localized structural rigidity and improved hybridization characteristics, enabling high sensitivity detection of small non-coding RNAs while reducing non-specific background binding through optimized probe design and hybridization conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides superior detection results compared to traditional formamide-based buffers, enabling robust and sensitive detection of microRNAs in FFPE samples, suitable for diagnostic tools like predicting disease-free survival in cancer patients.
Implementation Method 1
A formamide-free hybridization buffer containing chaotropic agents like urea or guanidine hydrochloride is used, which enhances detection sensitivity and specificity for small non-coding RNAs
Implementation Method 2
Together with Locked Nucleic Acid (LNA) comprising ISH probes the improved ISH buffer are useful for detection of specific nucleic acid molecules such as mRNA, rRNA and in particularly small non-coding RNA
Data Source
AI summary
An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.